Science News
Stay updated with the latest scientific news and research. Read press releases covering groundbreaking discoveries, innovations, and developments across various scientific fields. Keep up with the advancements and insights shaping the future of science.
Mar 27, 2025 at 3:00 AM
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
LONDON & NEW YORK--(BUSINESS WIRE)--ViroCell Biologics (“ViroCell” or the “Company”), a cell and gene therapy (“CGT”) contract development and manufacturing organization (“CDMO”) specializing in GMP viral vector manufacturing for clinical trials, announces the appointment of James Miskin as a Special Advisor. James will leverage expertise gained from a 25-year career in CGT to support ViroCell’s continued growth and technical development. James spent over 23 years at Oxford Biomedica (OXB), wit...
Mar 27, 2025 at 2:00 AM
Curatis: Sales growth of 30% in distribution - plus significant expansion of patient target group for lead project C-PTBE-01
LIESTAL, Switzerland--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, ‘Curatis’) reports business revenues of CHF 6.9m for 2024, whereby Curatis AG is only included for 8 months. Curatis AG was able to increase sales in the distribution business by 30% per cent to CHF 9.5m in the full year 2024 compared to 2023. Further key statements: Curatis is increasing the estimate for the number of patients addressed in the lead project C-PTBE-01 by a factor of 20. The reason for this is that Curatis can a...
Mar 27, 2025 at 2:00 AM
Innate Pharma Reports Full Year 2024 Financial Results and Business Update
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its consolidated financial results for the year ending December 31, 2024. The consolidated financial statements are attached to this press release. “Our strategy is clear: drive innovation through our ANKET® NK-cell engager platform and accelerate our ADC programs. We are making strong clinical progress, with our lead proprietary ANKET®, IPH6501 ad...
Mar 27, 2025 at 2:00 AM
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis
LILLE & PARIS, France--(BUSINESS WIRE)--Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis...
Mar 26, 2025 at 10:10 PM
Mitsubishi Electric Researcher Named Kaggle Competitions Master in World’s Largest AI Competition
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that Dr. Kenji Ueda, a researcher at the company’s Advanced Technology R&D Center in Japan, has been awarded the title of Kaggle Competitions Master by Kaggle, INC., a Google LLC subsidiary and the world’s largest AI competition platform. Kaggle medals recognize competitors who use superior skills in mathematical optimization or machine learning to develop effective solutions to challenges posed by compani...
Mar 26, 2025 at 7:19 PM
Redwire Announces Redemption of Outstanding Public Warrants
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW) (the “Company”), a leader in space infrastructure for the next generation space economy, today announced that it has completed the redemption of its publicly traded warrants (the “Warrants”) to purchase shares of the Company’s common stock, $0.0001 par value per share (“Common Stock”), that were issued under the Warrant Agreement, dated November 23, 2020, by and between the Company (f/k/a Genesis Park Acquisition Corp.) and Co...
Mar 26, 2025 at 7:00 PM
Pat Gelsinger Joins Playground Global as General Partner
PALO ALTO, Calif.--(BUSINESS WIRE)--Playground Global, a leading venture capital firm focused on early-stage deep tech, today announced that Pat Gelsinger is joining the firm as General Partner. A visionary leader in computing and semiconductor innovation, Gelsinger brings more than 45 years of experience driving technological advancements, most recently as CEO of Intel and previously as CEO of VMware. At Playground, Gelsinger will invest alongside fellow General Partners Peter Barrett, Jory Be...
Mar 26, 2025 at 4:45 PM
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), for up to $200 million. Access to the additional capital strengthens Savara’s balance sheet following the submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a tre...
Mar 26, 2025 at 4:30 PM
BWXT Launches Innovation Campus to Speed Development of Advanced Nuclear Technologies
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) today announced the opening of the BWXT Innovation Campus, a 170,000 square-foot facility that focuses on nuclear technology advancements for land, sea and space. The Lynchburg campus is home to BWXT’s Advanced Technologies business unit and its more than 350 team members. They will utilize its laboratories and workspaces to design, build and test advanced nuclear systems for NASA, the Department of Energy, Department of Defen...
Mar 26, 2025 at 4:05 PM
Spire Global Schedules Fourth Quarter and Full Year 2024 Results Conference Call
VIENNA, Va.--(BUSINESS WIRE)--Spire Global will hold a conference call on Monday, March 31, 2025 to discuss the Company’s fourth quarter and full year 2024 financial results....
- ...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.